Literature DB >> 23350720

Neuroprotection conferred by post-ischemia ethanol therapy in experimental stroke: an inhibitory effect on hyperglycolysis and NADPH oxidase activation.

Ryan Kochanski1, Changya Peng, Tetsuhiro Higashida, Xiaokun Geng, Maik Hüttemann, Murali Guthikonda, Yuchuan Ding.   

Abstract

Ethanol provides neuroprotection following ischemia/reperfusion. This study assessed ethanol's effect on hyperglycolysis and NADPH oxidase (NOX) activation. Adult, male Sprague-Dawley rats were subjected to middle cerebral artery occlusion (MCAO) for 2 h. Three sets of experiments were conducted to determine ethanol's effect on (i) conferring neuroprotection by measuring infarct volume and neurological deficits 24 h post reperfusion; (ii) cerebral glucose metabolism and lactic acidosis by measuring brain and blood glucose concentrations and protein expression of glucose transporter 1 and 3 (GLUT1, GLUT3), phosphofructokinase (PFK), as well as lactic acidosis by measuring lactate dehydrogenase (LDH), and lactate; and (iii) nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) activation by detecting enzymatic activity and subunit expression at 3 h after reperfusion. When administered upon reperfusion, ethanol (1.5 g/kg) reduced infarct volume by 40% (p < 0.01) and neurological deficits by 48% at 24 h post reperfusion while reducing (p < 0.01) elevations in glycolytic protein expression and lactate levels during early reperfusion (3 h). Ethanol increased the reductions in cerebral glucose concentration at 3 h post reperfusion by 64% (p < 0.01) while enhancing (p < 0.01) post stroke blood glucose concentration, suggesting a reduced cellular glucose uptake and utilization. Ethanol decreased (p < 0.01) stroke-induced NOX activation by reducing enzymatic activity and gp91(phox) expression by 45% and 38%, respectively. Post-ischemia ethanol treatment exerts neuroprotection through attenuation of hyperglycolysis and associated NOX activation. Because of the lack of associated hypoglycemia and selectivity toward decreasing cerebral metabolism, further investigation of ethanol's use as a post-stroke therapy, especially in the context of hyperglycemia, seems warranted.
© 2013 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23350720     DOI: 10.1111/jnc.12169

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

1.  Phosphoenolpyruvate Carboxykinase (PCK) in the Brain Gluconeogenic Pathway Contributes to Oxidative and Lactic Injury After Stroke.

Authors:  Xiaokun Geng; Jiamei Shen; Fengwu Li; James Yip; Longfei Guan; Gary Rajah; Changya Peng; Donald DeGracia; Yuchuan Ding
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

2.  Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke.

Authors:  Xiaokun Geng; Fengwu Li; James Yip; Changya Peng; Omar Elmadhoun; Jiamei Shen; Xunming Ji; Yuchuan Ding
Journal:  Mol Neurobiol       Date:  2016-11-28       Impact factor: 5.590

3.  [Salidroside protects PC12 cells from H2O2-induced apoptosis via suppressing NOX2-ROS-MAPKs signaling pathway].

Authors:  Zhi-Lin Qi; Yin-Hua Liu; Shi-Mei Qi; Lie-Feng Ling; Zun-Yong Feng; Qiang Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

4.  Neuroprotective Effects of Pharmacological Hypothermia on Hyperglycolysis and Gluconeogenesis in Rats after Ischemic Stroke.

Authors:  Longfei Guan; Hangil Lee; Xiaokun Geng; Fengwu Li; Jiamei Shen; Yu Ji; Changya Peng; Huishan Du; Yuchuan Ding
Journal:  Biomolecules       Date:  2022-06-19

5.  Neuroprotective effect of ethanol and Modafinil on focal cerebral ischemia in rats.

Authors:  Yusef Abbasi; Ronak Shabani; Kazem Mousavizadeh; Mansoureh Soleimani; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2019-01-15       Impact factor: 3.584

6.  Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.

Authors:  J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

7.  Controlled cortical impact results in an extensive loss of dendritic spines that is not mediated by injury-induced amyloid-beta accumulation.

Authors:  Charisse N Winston; Deepa Chellappa; Tiffany Wilkins; David J Barton; Patricia M Washington; David J Loane; David N Zapple; Mark P Burns
Journal:  J Neurotrauma       Date:  2013-10-12       Impact factor: 5.269

8.  Combining Normobaric Oxygen with Ethanol or Hypothermia Prevents Brain Damage from Thromboembolic Stroke via PKC-Akt-NOX Modulation.

Authors:  Lipeng Cai; James Stevenson; Xiaokun Geng; Changya Peng; Xunming Ji; Ruiqiang Xin; Radhika Rastogi; Christopher Sy; Jose A Rafols; Yuchuan Ding
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

9.  Normobaric oxygen therapy attenuates hyperglycolysis in ischemic stroke.

Authors:  Zhe Cheng; Feng-Wu Li; Christopher R Stone; Kenneth Elkin; Chang-Ya Peng; Redina Bardhi; Xiao-Kun Geng; Yu-Chuan Ding
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

10.  The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR.

Authors:  Shenglan Zeng; Ze Zhao; Shengnan Zheng; Mengting Wu; Xiaomeng Song; Yiquan Li; Yi Zheng; Bingyu Liu; Lin Chen; Chengjiang Gao; Huiqing Liu
Journal:  Redox Biol       Date:  2021-06-29       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.